Loading...

Canopy Growth Corporation

CGC•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$1.19
$-0.07(-5.56%)

Canopy Growth Corporation (CGC) Stock Overview

Explore Canopy Growth Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

C+

Score: 58.5/100

Key Financials

Market Cap246.1M
P/E Ratio-0.22
EPS (TTM)$-4.09
ROE-1.13%
Fundamental Analysis

AI Price Forecasts

1 Week$1.55
1 Month$0.54
3 Months$0.49
1 Year Target$0.74

CGC Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Canopy Growth Corporation (CGC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 43.75, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.74.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.22 and a market capitalization of 246.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Technical Indicators

43.75RSI (14)
-0.06MACD
14.30ADX
Stats data is not available for CGCStats details for CGC are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Analyst Recommendations

Strong Buy
0
Buy
0
Hold
0
Sell
1
Strong Sell
0

Price Targets

Low$0.00
Average$0.00
High$0.00

Company Profile

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.

CEO

Luc Mongeau

Employees

1,029

Headquarters

1 Hershey Drive, Smiths Falls, ON

Founded

2014

Frequently Asked Questions

;